(BPMC) Blueprint Medicines Renko charts technical analysis
(BPMC) Blueprint Medicines Renko charts technical analysis Renko analysis of Blueprint Medicines | Buy/Sell Blueprint Medicines
Blueprint Medicines trades in USA in Health Care sector.
10 day averaged volume of Blueprint Medicines is 3005650
| Date | Closing Price | Open | High | Low | Volume |
| 03 Thu Jul 2025 | 128.35 | 128.25 | 128.40 | 128.20 | 1.35 Mn |
| 02 Wed Jul 2025 | 128.20 | 128.35 | 128.45 | 128.20 | 2.318 Mn |
| 01 Tue Jul 2025 | 128.34 | 128.18 | 128.52 | 128.16 | 2.595 Mn |
| 30 Mon Jun 2025 | 128.18 | 128.30 | 128.32 | 128.08 | 2.35 Mn |
| 27 Fri Jun 2025 | 128.11 | 128.24 | 128.28 | 128.06 | 2.989 Mn |
| 26 Thu Jun 2025 | 128.15 | 128.29 | 128.31 | 128.10 | 2.53 Mn |
| 25 Wed Jun 2025 | 128.25 | 128.30 | 128.32 | 128.19 | 2.445 Mn |
| 24 Tue Jun 2025 | 128.26 | 128.40 | 128.40 | 128.15 | 3.377 Mn |
| 23 Mon Jun 2025 | 128.40 | 128.19 | 128.45 | 128.11 | 3.407 Mn |
| 20 Fri Jun 2025 | 128.20 | 128.27 | 128.30 | 128.00 | 4.506 Mn |
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.24 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Blueprint Medicines in short term but the sell signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 128.24 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.